| Announce Date | 12/10/2025 |
| EPS Normalized Actual | $2.26 (Beat by $0.62) |
| EPS GAAP Actual | $2.26 (Beat by $0.62) |
| Revenue Actual | $14.926B |
| Revenue Surprise | Beat by $14926M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| May 2030 | 18.125 | 9.84 | 16.95366 | 18.68197 | 4 |
| May 2029 | 10.18 | 17.53 | 10.01457 | 10.35046 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | 1.04 | 1.04 | 14.926B | 10.85% | 14926M |
| FQ2 2025 (May 2025) | 1.22 | 1.22 | 15.903B | 10.16% | 15903M |
| FQ1 2025 (Feb 2025) | 1.05 | 1.05 | 14.13B | 6.02% | 14130M |
| FQ4 2024 (Nov 2024) | -1.06 | -1.06 | 14.059B | 7.95% | 14059M |
| FQ3 2024 (Aug 2024) | 1.06 | 1.06 | 13.307B | 6.42% | 13307M |
| FQ2 2024 (May 2024) | 1.14 | 1.14 | 14.287B | 3.15% | 14287M |
| FQ1 2024 (Feb 2024) | 0.85 | 0.85 | 13.28B | 6.64% | 13280M |
| FQ4 2023 (Nov 2023) | 0.91 | 0.91 | 12.941B | 5.15% | 12941M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2029 (Nov 2029) | 5.05 | -- | 4.96831 | 5.13667 | 9 |
| FQ3 2029 (Aug 2029) | 4.62 | -- | 4.51658 | 4.73169 | 8 |
| FQ2 2029 (May 2029) | 4.71 | -- | 4.60456 | 4.82386 | 11 |
| FQ1 2029 (Feb 2029) | 4.16 | -- | 4.09271 | 4.2314 | 9 |
| FQ4 2028 (Nov 2028) | 3.785 | -- | 3.72377 | 3.84996 | 10 |
| FQ3 2028 (Aug 2028) | 3.37 | -- | 3.29456 | 3.45147 | 9 |
| FQ2 2028 (May 2028) | 3.26925 | -- | 3.19606 | 3.34828 | 9 |
| FQ1 2028 (Feb 2028) | 2.54987 | -- | 2.52276 | 2.58787 | 14 |
| FQ4 2027 (Nov 2027) | 2.44269 | -- | 2.41672 | 2.47909 | 13 |
| FQ3 2027 (Aug 2027) | 2.13985 | -- | 2.09195 | 2.19158 | 14 |
| FQ2 2027 (May 2027) | 2.34521 | -- | 2.32643 | 2.37261 | 12 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2029 (Nov 2029) | 55.04B | -- | 54.36B | 55.77B | 9 |
| FQ3 2029 (Aug 2029) | 52.54B | -- | 51.64B | 53.52B | 9 |
| FQ2 2029 (May 2029) | 52.63B | -- | 51.72B | 53.61B | 12 |
| FQ1 2029 (Feb 2029) | 47.83B | -- | 47.23B | 48.46B | 16 |
| FQ4 2028 (Nov 2028) | 44.28B | -- | 43.73B | 44.86B | 8 |
| FQ3 2028 (Aug 2028) | 40.3B | -- | 39.6B | 41.04B | 13 |
| FQ2 2028 (May 2028) | 38.78B | -- | 38.11B | 39.5B | 8 |
| FQ1 2028 (Feb 2028) | 24.08B | -- | 23.88B | 24.35B | 20 |
| FQ4 2027 (Nov 2027) | 23.33B | -- | 23.14B | 23.6B | 22 |
| FQ3 2027 (Aug 2027) | 26.99B | -- | 26.52B | 27.49B | 9 |
| FQ2 2027 (May 2027) | 20.29B | -- | 20.17B | 20.47B | 17 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | 1.04 | 1.04 | 100% | |
| FQ2 2025 (May 2025) | 1.22 | 1.22 | 100% | |
| FQ1 2025 (Feb 2025) | 1.05 | 1.05 | 100% | |
| FQ4 2024 (Nov 2024) | -1.06 | -1.06 | 100% | |
| FQ3 2024 (Aug 2024) | 1.06 | 1.06 | 100% | |
| FQ2 2024 (May 2024) | 1.14 | 1.14 | 100% | |
| FQ1 2024 (Feb 2024) | 0.85 | 0.85 | 100% | |
| FQ4 2023 (Nov 2023) | 0.91 | 0.91 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | $0B | $14.93B | $14926M | 100% |
| FQ2 2025 (May 2025) | $0B | $15.9B | $15903M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $14.13B | $14130M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $14.06B | $14059M | 100% |
| FQ3 2024 (Aug 2024) | $0B | $13.31B | $13307M | 100% |
| FQ2 2024 (May 2024) | $0B | $14.29B | $14287M | 100% |
| FQ1 2024 (Feb 2024) | $0B | $13.28B | $13280M | 100% |
| FQ4 2023 (Nov 2023) | $0B | $12.94B | $12941M | 100% |